Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Dirk Van de Put Plans 129,285-Share Mondelez Sale

Mondelez International Inc Chairman and CEO Dirk Van de Put filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 129,285 shares of Mondelez common stock through a Rule 10b5-1 plan adopted on May 15, 2026.

Aditi Sarkar | 04 November 2026

LaRosa Exercises and Sells Regeneron Shares Nov. 2, 2026

Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on November 4, 2026 disclosing a series of transactions in the company's common stock executed on November 2, 2026.

Aditi Sarkar | 04 November 2026

Fenimore Exercises 6,000 Options, Sells Shares at $950.50

Christopher R. Fenimore, EVP Finance and CFO of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on November 4, 2026, disclosing multiple transactions in Regeneron common stock dated November 2, 2026.

Nitish Kishor | 04 November 2026

Regeneron Director George Sing Sells 21,129 Shares on Nov 2

Director George L. Sing of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) filed a Form 4 on November 4, 2026, disclosing option exercises and open-market share sales totaling 21,129 shares on November 2, 2026.

Manish Choudhary | 04 November 2026

Christine Poon Exercises Options, Sells 7,830 Shares at Regeneron

Director Christine A. Poon filed a Form 4 with the SEC on November 4, 2026, disclosing the exercise of a non-qualified stock option and the sale of 7,830 shares of Regeneron Pharmaceuticals, Inc. common stock on November 2, 2026.

Aditi Sarkar | 04 November 2026

Regeneron Officer Pitofsky Plans 3,883-Share Sale via Rule 144

Jason Pitofsky, an officer of Regeneron Pharmaceuticals Inc, filed a Form 144 notice of proposed sale on November 4, 2026, covering 3,883 shares of common stock to be sold through UBS Financial Services Inc on NASDAQ:REGN.

Manish Choudhary | 04 November 2026

Jason Pitofsky Files to Sell 180 Inherited Regeneron Shares

Jason Pitofsky, an officer of Regeneron Pharmaceuticals, Inc., filed a Form 144 notice of proposed sale on November 4, 2026, covering 180 shares of Regeneron common stock acquired through inheritance.

Manish Choudhary | 04 November 2026

James Saccaro Plans 78,348-Share GE HealthCare Sale

James Saccaro, a former officer of GE HealthCare Technologies Inc., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 78,348 shares of common stock on NASDAQ:GEHC.

Manish Choudhary | 04 November 2026

Landmark Bancorp Director Alexander Files to Sell 2,020 Shares

Director Patrick L. Alexander of Landmark Bancorp Inc filed a Form 144 notice of proposed sale on November 4, 2026, covering 2,020 common shares with an aggregate market value of $65,650.00, to be sold on NASDAQ through RBC Capital Markets LLC.

Aakashdeep | 04 November 2026

James Namkung Plans to Sell 3,777 ICE Shares Under Rule 144

Intercontinental Exchange, Inc. officer James Namkung filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 3,777 shares of common stock on the NYSE with an aggregate market value of $645,602.61.

Nitish Kishor | 04 November 2026
Support

Hi! How can we help you today?

Loading…